BriaCell Therapeutics Corp. (TSE:BCT – Get Free Report) shot up 20.8% on Friday. The company traded as high as C$5.79 and last traded at C$5.57. Approximately 21,391 shares traded hands during mid-day trading, an increase of 42% from the average daily volume of 15,016 shares. The stock had previously closed at C$4.61.
BriaCell Therapeutics Stock Up 20.8%
The stock’s 50-day moving average price is C$5.22 and its 200-day moving average price is C$5.25. The company has a market capitalization of C$48.64 million, a price-to-earnings ratio of -0.80 and a beta of 1.53.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients’ lives. Immunotherapies have become the forefront of the fight against cancer because they use the body’s immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-corp-logo-1200x675.jpg){kind=logo}
